Sabril Tablets and Granules Concerns Raised
Sign-up to one of our many Group Actions today - use our quick and easy form to start your claim for compensation.
Begin Your Group Action Claim Today
Sign-up to one of our many Group Actions today - use our quick and easy form to start your claim for compensation.
Potential concerns that have arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.
The medications, manufactured by Aventis Pharma Limited (a subsidiary of Sanofi), have reportedly been subject to advice issued by The Medicines and Healthcare products Regulatory Agency (MHRA). The regulator has covered the issue of a precautionary recall for Sabril 500 mg film-coated tablets and Sabril 500 mg granules for oral solution (EL 23/A25).
The MHRA has publicised details about the precautionary recall of Sabril 500 mg film-coated tablets and Sabril 500 mg granules for oral solution due to: “the detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin”.
This deviation could impact the medication’s efficacy and potentially its safety. Patients who depend on Sabril tablets and granules for the management of conditions like epilepsy deserve medication that meets rigorous quality standards.
This precautionary recall has prompted concerns over potential harm or inconvenience that may be caused by Sabril tablets and granules. Hopefully, as the publications indicate, the risks are low and no one will be harmed.
When multiple individuals are affected by the same issue, pursuing legal action individually can be overwhelming and less effective. A Group Action, also known as a class action lawsuit, can allow a group of people with similar claims to collectively seek compensation from the responsible party.
In such cases, individuals who have experienced adverse effects or any negative impact due to such problems can join forces in a group action to maximise their chances of receiving fair compensation. Further, some cases may need to be put together in a formal Group Litigation Order (GLO) action to be able to benefit from a settlement.
At The Group Action Lawyers, we specialise in representing individuals in complex cases involving defective medications and medical devices. If, for example, the Sabril tablets and granules issues result in any harm to many people, victims could theoretically form a group action case.
Our experienced legal team understands the intricacies of group action lawsuits and is dedicated to helping affected individuals pursue the compensation they deserve. From gathering evidence of the impact on your health to building a robust case against a Defendant, our experts are committed to ensuring your rights are protected throughout the legal process.
Gather Information: Start by gathering all relevant information about your involvement in an issue. This could include medical records, prescription histories for medical matters, and any documentation of adverse effects or health complications.
Consult Legal Experts: Reach out to The Group Action Lawyers for a free, no-obligation consultation. Our legal team can evaluate your case, inform you about your eligibility for a group action, and guide you through the necessary steps.
Join the Group Action: If you decide to proceed, we can help you join a formal group action, which may involve combining your claim with those of other affected individuals. This collective effort enhances the strength of your case.
Evidence Collection: Our legal professionals can work closely with you to gather further evidence, demonstrating the impact on you. This may involve expert medical opinions and other forms of documentation as well.
Negotiation and Compensation: We can represent your interests during negotiations and fight for fair compensation on your behalf. Our goal is to ensure that your suffering and losses are acknowledged and appropriately compensated.
The content of this post/page was considered accurate at the time of the original posting and/or at the time of any posted revision. The content of this page may, therefore, be out of date. The information contained within this page does not constitute legal advice. Any reliance you place on the information contained within this page is done so at your own risk.